shock is a serious condition that occurs when the heart cannot pump enough blood and oxygen to the brain, kidneys, and other vital organs.
On May 21, investigators published in Catheterization and Cardiovascular Interventions (CCI) and presented at the 2019 SCAI Scientific Sessions, updated clinical data from the National Cardiogenic
Shock Initiative Study (NCSI).
Patients who had higher HbA1c >6.5% had higher incidence of Cardiogenic
shock compared to patients with HbA1c <6.4%.
- The US FDA has approved the expansion of the Impella 5.0 and Impella LD PMA labeling for the treatment of cardiogenic
shock, US-based Abiomed (NASDAQ: ABMD) said.
Cardiac arrest before PCI occurred 8.1% and 14% had cardiogenic
shock on presentation.
In CCU, IABP is mainly used as preoperative support for high-risk patients undergoing coronary artery bypass graft (CABG) surgery, and for haemodynamic support, post-percutaneous coronary intervention (PCI), in patients with acute MI complicated with cardiogenic
PCI strategies in patients with acute myocardial infarction and cardiogenic
In severe cases of sepsis-triggered Takotsubo cardiomyopathy, septic shock and cardiogenic
shock can be difficult to distinguish.
The frequency of cardiogenic
shock was the same for TTS and AMI (5.7 percent).
[USPRwire, Mon Oct 08 2018] Global Cardiogenic
Shock Market: Snapshot The global cardiogenic
shock market is driven by the rising prevalence of cardiac conditions across the world.
Herein, we described the use of venoarterial ECMO in a patient with severe cardiogenic
shock because of incessant junctional ectopic tachycardia with no response to conventional therapy.